- Home
- WALD vs STIM Comparison
WALD vs STIM Comparison
Compare WALD & STIM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WALD
- STIM
- Stock Information
- Founded
- WALD 1988
- STIM 2003
- Country
- WALD United States
- STIM United States
- Employees
- WALD N/A
- STIM N/A
- Industry
- WALD Package Goods/Cosmetics
- STIM Medical/Dental Instruments
- Sector
- WALD Consumer Discretionary
- STIM Health Care
- Exchange
- WALD Nasdaq
- STIM Nasdaq
- Market Cap
- WALD 228.8M
- STIM 224.8M
- IPO Year
- WALD 2021
- STIM 2018
- Fundamental
- Price
- WALD $1.89
- STIM $2.69
- Analyst Decision
- WALD Strong Buy
- STIM Strong Buy
- Analyst Count
- WALD 5
- STIM 2
- Target Price
- WALD $4.96
- STIM $7.00
- AVG Volume (30 Days)
- WALD 89.5K
- STIM 1.1M
- Earning Date
- WALD 11-11-2025
- STIM 11-11-2025
- Dividend Yield
- WALD N/A
- STIM N/A
- EPS Growth
- WALD N/A
- STIM N/A
- EPS
- WALD N/A
- STIM N/A
- Revenue
- WALD $273,868,000.00
- STIM $111,106,000.00
- Revenue This Year
- WALD $10.37
- STIM $105.70
- Revenue Next Year
- WALD $14.37
- STIM $11.77
- P/E Ratio
- WALD N/A
- STIM N/A
- Revenue Growth
- WALD 25.55
- STIM 54.17
- 52 Week Low
- WALD $1.48
- STIM $0.52
- 52 Week High
- WALD $4.18
- STIM $5.92
- Technical
- Relative Strength Index (RSI)
- WALD 49.65
- STIM 42.01
- Support Level
- WALD $1.80
- STIM $2.65
- Resistance Level
- WALD $2.07
- STIM $3.21
- Average True Range (ATR)
- WALD 0.13
- STIM 0.19
- MACD
- WALD -0.01
- STIM 0.03
- Stochastic Oscillator
- WALD 33.33
- STIM 22.22
About WALD Waldencast plc
Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.
About STIM Neuronetics Inc.
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.